|
ZNF516 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.24380000427516E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.94789999971879E-07 |
| Normal-vs-Stage2 |
4.25740000000729E-05 |
| Normal-vs-Stage3 |
6.09239999560529E-08 |
| Normal-vs-Stage4 |
2.59450000039685E-07 |
| Stage1-vs-Stage2 |
4.833200E-01 |
| Stage1-vs-Stage3 |
3.992000E-01 |
| Stage1-vs-Stage4 |
1.705240E-01 |
| Stage2-vs-Stage3 |
9.173400E-01 |
| Stage2-vs-Stage4 |
7.626800E-01 |
| Stage3-vs-Stage4 |
6.091600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83349999627325E-08 |
| Normal-vs-AfricanAmerican |
4.453000E-01 |
| Normal-vs-Asian |
1.52232999999224E-05 |
| Caucasian-vs-AfricanAmerican |
8.097700E-02 |
| Caucasian-vs-Asian |
6.065200E-01 |
| AfricanAmerican-vs-Asian |
6.056300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31010000018017E-08 |
| Normal-vs-Female |
2.70659999968004E-07 |
| Male-vs-Female |
5.747900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.60040000005435E-06 |
| Normal-vs-Age(41-60Yrs) |
4.85119999948935E-07 |
| Normal-vs-Age(61-80Yrs) |
9.70730051896851E-10 |
| Normal-vs-Age(81-100Yrs) |
5.844600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.650800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.801900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.908200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.716300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.557000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.465400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.069600E-02 |
| Classical-VS-Follicular |
4.06799999996821E-06 |
| Classical-VS-Other |
6.087800E-01 |
| Classical-VS-Normal |
3.49799999999068E-06 |
| Tall-VS-Follicular |
1.767420E-01 |
| Tall-VS-Other |
9.532800E-01 |
| Tall-VS-Normal |
7.98980000049632E-07 |
| Follicular-VS-Other |
5.313800E-01 |
| Follicular-VS-Normal |
5.34799982077061E-10 |
| Other-VS-Normal |
3.201900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04149999525083E-09 |
| Normal-vs-N1 |
2.46979999996011E-06 |
| N0-vs-N1 |
9.782000E-01 |
|
|
